To access the full report, click on the PDF (only visible when logged-in).
Amgen, Inc. – AMGN: Confirmed, Undisclosed SEC Investigation. We tracked undisclosed SEC investigative activity off-and-on at Amgen dating back to Sep-2013. The first Freedom of Information Act (FOIA) response indicating a new SEC investigation was dated 18-Apr-2019, and later confirmed in an appeal response dated 23-May-2019.
Clients are invited to contact us anytime, in total confidence, to discuss how to better assess the risks we identify here.
Note: New SEC investigative activity could theoretically begin or end after the date covered by this latest information which would not be reflected here.